The Lynx Group
Association for Value-Based Care
AVBCC COVID-19 Impact on the Cancer Care Delivery Ecosystem Webcast Series

COVID-19 Impact on the Cancer Care Delivery Ecosystem

LIVE Webcast Series

AVBCC COVID-19 Webcast Series Replays

May 27, 2020: An Actuarial View of COVID-19: Payers, Providers, Healthcare Reform: COVID-19 Impact on Cancer Care and Road to Recovery

May 22, 2020: Economic Observations: COVID-19 Impact on Cancer Care and Road to Recovery

May 21, 2020: Oncology Nursing and Cancer Care: COVID-19 Impact on Cancer Care and Road to Recovery

May 20, 2020: Washington and Public Policy: COVID-19 Impact on Cancer Care and Road to Recovery

May 14, 2020: Employers: COVID-19 Impact on Cancer Care and Road to Recovery

May 13, 2020: Telehealth: COVID-19 Impact on Cancer Care and Road to Recovery

May 12, 2020: Research and Investigational Studies: COVID-19 Impact on Cancer Care and Road to Recovery

May 7, 2020: Oncology Pharmacy: COVID-19 Impact on Cancer Care and Road to Recovery
In this discussion, moderated by Niesha Griffith, RPh, MS, FASHP, CPO (interim), a panel of oncology pharmacists discuss the impact of the COVID-19 pandemic on their practices, the increase in the use of new technologies as a result of recent events, and how the influx of patients expected in the coming weeks will affect their daily operations.
Read More

May 6, 2020: Pharmaceutical Manufacturers: COVID-19 Impact on Cancer Care and Road to Recovery
Pharmaceutical support and innovation are vital to the effective treatment of patients with cancer. In this discussion, moderated by Burt Zweigenhaft, PhD, D.Litt, a panel of experts discussed the importance of maintaining an adequate supply of medicines for patients, and the need for philanthropic programs to ensure patients will be able to continue their medications, even if they lose their health insurance.
Read More

May 5, 2020: Community Cancer Care Providers: COVID-19 Impact on Cancer Care and Road to Recovery
Large community care centers remain committed to providing necessary treatment to patients with cancer during the COVID-19 pandemic. In this discussion, moderated by Ted Okon, MBA, a panel of experts discuss the ongoing challenges that oncology providers face as they navigate an evolving healthcare ecosystem, and provide valuable insights on how practices may continue to deliver care in the months ahead.
Read More

Page 1 of 2

Thank You to our Webcast Series Supporters

  • Integra Connect
  • Mylan
  • Sun Pharma
  • AmerisourceBergen
  • Amgen Oncology
  • Bristol-Myers Squibb
  • Merck
  • Sanofi Genzyme
  • Daiichi Sankyo
  • Eisai
  • FFF Enterprises
  • Janssen Oncology

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to recieve the free VBCC print publication or weekly e‑Newsletter.

I'd like to recieve: